Skip to main content
. 2020 Jun 21;12(6):1644. doi: 10.3390/cancers12061644

Figure 2.

Figure 2

UHPLC-MS-based lipidomic analysis of bile samples from patients with benign stenoses (controls) and patients with CCA (cholangiocarcinoma) or PDAC (pancreatic adenocarcinoma). Lipid species shown include phosphatidylcholines (PC), lysophosphatidylcholines (LPC), PC-plasmenyles, PC-plasmanyles, fatty acid amines (FAA), monoglycerides (MG), diglycerides (DG), triglycerides (TG), sphingomyelins (SMs) and ceramides (Cer).